IL15 and graft versus host disease: The “protective” role of NK cells in the pathogenesis of GVHD has been questioned; in another study [46], patients who received transfusion of donor IL-15/4-1BBL-activated NK cells after haplo-HSCT with T cell depletion had a higher risk of GVHD.